Methodology

Last updated: April 17, 2026

MEDVi is structured around a high-intent homepage, two focused GLP-1 solution pages, topic hubs, and trust pages rather than a generic homepage-plus-blog setup. The goal is to help visitors understand treatment pathways, self-pay expectations, and clinician-review context before they click through.

1. Page architecture

Homepage for category framing, offer summary, and links to the most important paths
Solution pages for GLP-1 injections and GLP-1 tablets
Topic hubs for broader questions around workflow, delivery format, and support expectations
Trust pages for methodology, editorial standards, evidence review, authorship, and company context

2. Commercial page rules

Each commercial page is expected to do one job well:

Match one dominant user intent
Explain the process before the CTA
Link to policy and trust pages where those questions matter
Avoid claims that imply the page itself provides medical care

3. Evidence and policy standards

Educational pages are planned and updated under the editorial and evidence review policies. Those pages exist to make sourcing, claim style, and correction practices visible to readers.

4. Internal linking logic

Home links to both GLP-1 solution pages and the topic hubs that matter most
Each GLP-1 solution page links to relevant hubs and proof pages
Hub pages link onward to the correct commercial page and supporting proof pages
Policy and profile pages stay reachable through navigation, footer links, and trust sections

5. Disclosure model

This site may participate in compensated referral relationships, while licensed clinicians make all clinical decisions, including eligibility, prescribing, and follow-up. The experience is designed to keep that separation visible in content, metadata, and policy pages.

6. Launch notes

MEDVi states that it operates in all 50 states and frames its GLP-1 offer around a $179 injection start price, a $249 tablet start price, no hidden fees, fast delivery, and 24/7 support when prescribed.